Practical clues for diagnosing WWOX encephalopathy.

Area of Science:

• Neurogenetics
• Epileptology
• Molecular Biology

Background:

• Autosomal recessive disorders linked to the WW domain-containing oxidoreductase (WWOX) gene manifest as spinocerebellar ataxia or severe early-infantile epileptic encephalopathy.
• Understanding the full spectrum and diagnostic criteria for WWOX-related neurological disorders is crucial for timely intervention.

Observation:

• A case study of a boy with early-onset epilepsy revealed profound global developmental delay, persistent hypsarrhythmia, and epileptic spasms.
• The patient exhibited progressive cerebral atrophy without microcephaly, and metabolic diseases were ruled out.
• Whole-exome sequencing identified mutations in the WWOX gene.

Findings:

• The findings expand the phenotypic spectrum of WWOX encephalopathy, highlighting persistent epileptic spasms and hypsarrhythmia as key features.
• Microcephaly is not a mandatory diagnostic criterion, even with progressive cerebral atrophy.
• WWOX gene mutations may be more prevalent in early-onset epileptic encephalopathies than previously thought.

Implications:

• This research provides practical diagnostic clues for WWOX encephalopathy, aiding in the avoidance of unnecessary investigations.
• Early and accurate diagnosis facilitates appropriate genetic counseling for affected families.
• Further research into WWOX gene mutations could uncover more frequent associations with early-onset epileptic encephalopathies.